Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

NanoString Technologies, Inc. NSTG NASDAQ

NASDAQ Global Market • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
39/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$21.50
+20317.9%

NanoString Technologies, Inc. (NSTG) is a Medical - Instruments & Supplies company in the Healthcare sector, currently trading at $0.11. It has a SharesGrow Score of 39/100, indicating a weak investment profile with 2 out of 7 criteria passed.

Analyst consensus target is NSTG = $22 (+20317.9% upside).

Financials: revenue is $127M, +1.6%/yr average growth. Net income is $160M (loss), growing at -71.2%/yr. Net profit margin is -125.4% (negative). Gross margin is 48.6% (-16.3 pp trend).

Balance sheet: total debt is $251M against $46M equity (Debt-to-Equity (D/E) ratio 5.47, leveraged). Current ratio is 4.87 (strong liquidity). Debt-to-assets is 70.9%. Total assets: $353M.

Analyst outlook: 7 / 13 analysts rate NSTG as buy (54%) — moderate consensus.

SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 30/100 (Fail), Past 0/100 (Fail), Health 33/100 (Fail), Moat 36/100 (Fail), Future 64/100 (Pass), Income 10/100 (Fail).

$21.50
▲ 20317.85% Upside
Average Price Target
Based on 13 Wall Street analysts offering 12-month price targets for NanoString Technologies, Inc., the average price target is $21.50, with a high forecast of $28.00, and a low forecast of $15.00.
Highest Price Target
$28.00
Average Price Target
$21.50
Lowest Price Target
$15.00

NSTG SharesGrow Score Overview

46/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 100/100
Valuation — P/E, PEG, Forward PEG
GROWTH 30/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 33/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 36/100
Gross margin is + market cap
FUTURE 64/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — NSTG

✓
VALUE Pass
100/100
NSTG trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Analyst consensus target is $22, implying +20792.7% from the current price $0. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
✗
GROWTH Fail
30/100
NSTG: +1.6%/yr revenue is, -71.2%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
✗
HEALTH Fail
33/100
Balance sheet NSTG: Debt-to-Equity (D/E) ratio 5.47 (leveraged), Current ratio is 4.87 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
36/100
NSTG: Gross margin is 48.6% (-16.3 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 36/100. ≥ 70 = Pass.
View details →
✓
FUTURE Pass
64/100
Analyst outlook: 7 / 13 analysts rate NSTG as buy (54%). Analyst consensus target is $22 (+20792.7% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
✗
INCOME Fail
10/100
NSTG: Net profit margin is -125.4%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.1025-0.13999
Volume21.43M
Avg Volume (30D)21.43M
Market Cap$5.07M
Beta (1Y)1.24
Share Statistics
EPS (TTM)-3.44
Shares Outstanding$46.41M
IPO Date2013-06-26
Employees550
CEOR. Bradley Gray
Financial Highlights & Ratios
Revenue (TTM)$127.26M
Gross Profit$61.79M
EBITDA$-143.58M
Net Income$-159.54M
Operating Income$-152.18M
Total Cash$196.53M
Total Debt$250.5M
Net Debt$138.25M
Total Assets$353.41M
Price / Earnings (P/E)-0
Price / Sales (P/S)0.04
Analyst Forecast
1Y Price Target$21.50
Target High$28.00
Target Low$15.00
Upside+20,317.9%
Rating ConsensusBuy
Analysts Covering13
Buy 54% Hold 46% Sell 0%
Company Info
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS63009R1095

Price Chart

Track all markets on TradingView
NSTG
NanoString Technologies, Inc. ↗  ·  NASDAQ Global Market
Healthcare • Medical - Instruments & Supplies
0.10 52WK RANGE 0.14

People Also View

TXG
TXG
10x Genomics, Inc.
$24.80
+5.17%
 VCYT
VCYT
Veracyte, Inc.
$34.30
+5.73%
 IOVA
IOVA
Iovance Biotherapeutics, Inc.
$3.64
+5.20%
 MCRB
MCRB
Seres Therapeutics, Inc.
$8.61
+0.35%
 SYRS
SYRS
Syros Pharmaceuticals, Inc.
$0.00
-12.50%
 LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
 JNJ
JNJ
Johnson & Johnson
$240.10
+0.90%
 ABBV
ABBV
AbbVie Inc.
$210.32
+1.86%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message